These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18336285)
1. A possible placental factor for preeclampsia: sFlt-1. Kita N; Mitsushita J Curr Med Chem; 2008; 15(7):711-5. PubMed ID: 18336285 [TBL] [Abstract][Full Text] [Related]
2. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808 [TBL] [Abstract][Full Text] [Related]
3. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201 [TBL] [Abstract][Full Text] [Related]
4. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM; Roland MC; Henriksen T; Michelsen TM Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [TBL] [Abstract][Full Text] [Related]
6. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761 [TBL] [Abstract][Full Text] [Related]
7. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy. Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493 [TBL] [Abstract][Full Text] [Related]
8. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia. Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1. Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319 [TBL] [Abstract][Full Text] [Related]
10. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells. Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343 [TBL] [Abstract][Full Text] [Related]
11. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809 [TBL] [Abstract][Full Text] [Related]